Bristol-Myers Squibb - 48 Year Stock Split History | BMY

Stock split history for Bristol-Myers Squibb since 1972. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Bristol-Myers Squibb Annual Stock Splits
Bristol-Myers Squibb Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $107.060B $26.145B
Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $392.415B 17.16
Roche Holding AG (RHHBY) Switzerland $306.333B 0.00
Novartis AG (NVS) Switzerland $222.809B 18.55
Merck (MRK) United States $208.771B 15.80
Pfizer (PFE) United States $200.501B 12.28
Novo Nordisk (NVO) Denmark $151.884B 26.07
AbbVie (ABBV) United States $139.216B 10.53
Eli Lilly (LLY) United States $135.215B 23.32
AstraZeneca (AZN) United Kingdom $129.378B 27.86
Sanofi (SNY) France $126.985B 15.09
GlaxoSmithKline (GSK) United Kingdom $108.520B 13.76
Bayer (BAYRY) Germany $76.171B 11.28
H Lundbeck (HLUYY) Denmark $7.755B 13.47